SP1 and cancer: Previously, we explored the concept that SP1, HIF1A, and MYC collaborate together to promote cancer development, based on comprehensive investigations of various system analyses of cancer-related genes and promoter analyses of SP1, MYC, and HIF1A, and that the inhibition of the expression of all of these transcription factors might be a key to suppressing cancer development [15].